Y-Intercept (HK)’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $552K | Sell |
104,002
-8,982
| -8% | -$47.7K | 0.01% | 1173 |
|
|
2025
Q1 | $1M | Buy |
112,984
+60,317
| +115% | +$535K | 0.07% | 405 |
|
|
2024
Q4 | $722K | Buy |
52,667
+14,134
| +37% | +$194K | 0.05% | 564 |
|
|
2024
Q3 | $1.06M | Buy |
38,533
+25,179
| +189% | +$690K | 0.06% | 429 |
|
|
2024
Q2 | $327K | Buy |
+13,354
| New | +$327K | 0.02% | 1001 |
|
|
2024
Q1 | – | Sell |
-20,905
| Closed | -$400K | – | 1625 |
|
|
2023
Q4 | $400K | Buy |
20,905
+1,357
| +7% | +$26K | 0.04% | 705 |
|
|
2023
Q3 | $314K | Buy |
+19,548
| New | +$314K | 0.03% | 752 |
|
|
2023
Q1 | – | Sell |
-40,706
| Closed | -$591K | – | 1415 |
|
|
2022
Q4 | $591K | Buy |
+40,706
| New | +$591K | 0.09% | 372 |
|